![Wendy Erler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wendy Erler
Directeur/Bestuurslid bij Huntington's Disease Society of America
Actieve functies van Wendy Erler
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Huntington's Disease Society of America | Directeur/Bestuurslid | - | - |
Rare-X
![]() Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Directeur/Bestuurslid | - | - |
Loopbaan van Wendy Erler
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 2 |
Sectoraal
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Huntington's Disease Society of America | |
Rare-X
![]() Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Technology Services |
- Beurs
- Insiders
- Wendy Erler
- Ervaring